arrow
Back
E

Eleni Andreopoulou

George Mason University

33H-index
231Paper Count
4.2KCitation Count
Published Papers 51
Publication Date
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
err2025-08-16
err0
errOAAI
errLetizia Pontolillo; Andrew A. Davis; Lorenzo Gerratana; Arielle J. Medford; Judy Wang; Eleonora Nicolo’; Katherine Clifton; Marko Velimirovic; Surbhi Warrior; Emily Podany; Eleni Andreopoulou; Mara Serena Serafini; Laura Munoz-Arcos; Elisabetta Molteni; Marla Lipsyc-Sharf; Caterina Gianni; Nadia Bayou; Charles S. Dai; Diana Giannarelli; Emilio Bria; Cynthia X. Ma; Aditya Bardia; Carolina Reduzzi; Massimo Cristofanilli
errShare
errSave
Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling
errSCIENCE
IF45.8
err2025-03-14
err3
PREAI
errKoundouros, Nikos; Nagiec, Michal J.; Bullen, Nayah; Noch, Evan K.; Burgos-Barragan, Guillermo; Li, Zhongchi; He, Long; Cho, Sungyun; Parang, Bobak; Leone, Dominique; Andreopoulou, Eleni; Blenis, John
errShare
errSave
Integrative Whole Genome and Transcriptome Sequencing (WGTS) Analysis of a Pan Cancer Cohort Unearths Novel Therapeutic Avenues
err2025-03-01
err0
PREAI
errKozan, Eda Nur; Al Assaad, Majd; Levine, Max; Manohar, Jyothi; Sigouros, Michael; Wilkes, David; Semaan, Alissa; Medina-Martinez, Juan; Chapman-Davis, Eloise; Sternberg, Cora; Andreopoulou, Eleni; Sboner, Andrea; Tagawa, Scott; Nanus, David; Mosquera, Juan Miguel
errShare
errSave
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases
err2024-12-01
err0
PREAI
errIvanidze, Jana; Sharbatdaran, Arman; McCalla, Aliah; Brandmaier, Andrew; Andreopoulou, Eleni; Cristofanilli, Massimo; Cigler, Tessa; Balogun, Onyinye D.; Magge, Rajiv S.; Liechty, Benjamin; Karakatsanis, Nicolas A.; Nehmeh, Sadek A.; Agee, Matthew A.; Jean, Jolie; Osborne, Joseph R.; Beal, Kathryn; Schwartz, Theodore H.; Pannullo, Susan C.; Knisely, Jonathan P. S.; Ramakrishna, Rohan
errShare
errSave
Association between BRCA alterations detected by circulating tumor DNA and germline mutations in breast cancer patients: a retrospective mono-institutional analysis
err2024-05-02
err0
PREAI
errPontolillo, Letizia; Nicolo, Eleonora; Arcos, Laura Munoz; Reduzzi, Carolina; Serafini, Mara Serena; Strickland, Amanda Kaylan; Bayou, Nadia; Donahue, Jeannine; Molteni, Elisabetta; Gerratana, Lorenzo; Giannarelli, Diana; Andreopoulou, Eleni; Bria, Emilio; Cristofanilli, Massimo
errShare
errSave
Whole genome and transcriptome sequencing of a pan cancer cohort unearths novel therapeutic avenues
err2023-04-04
err0
PREAI
errAl Assaad, Majd; Kuo, Hui-Hsuan; Nauseef, Jones; Levine, Max F.; Gundem, Gunes; Medina-Martinez, Juan S.; Manohar, Jyothi; Sigouros, Michael; Elsaeed, Ahmed; Wilkes, David; Papaemmanuil, Elli; Chapman, Eloise; Tagawa, Scott T.; Ocean, Allyson; Sternberg, Cora N.; Andreopoulou, Eleni; Shah, Manish; Sboner, Andrea; Holcomb, Kevin; Nanus, David; Martin, Laura; Elemento, Olivier; Mosquera, Juan Miguel
errShare
errSave
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
err2023-01-10
err5
errOAAI
errSchreier, Ashley; Zappasodi, Roberta; Serganova, Inna; Brown, Kristy A.; Demaria, Sandra; Andreopoulou, Eleni
errShare
errSave
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
err2022-01-13
err10
errOAAI
errFasano, Genevieve A.; Bayard, Solange; Chen, Yalei; Varella, Leticia; Cigler, Tessa; Bensenhaver, Jessica; Simmons, Rache; Swistel, Alexander; Marti, Jennifer; Moore, Anne; Andreopoulou, Eleni; Ng, John; Brandmaier, Andrew; Formenti, Silvia; Ali, Haythem; Davis, Melissa; Newman, Lisa
errShare
errSave
Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancer
err2021-11-15
err2
errOAAI
errOrfanelli, Theofano; Giannopoulos, Spyridon; Zografos, Eleni; Athanasiou, Aikaterini; Bongiovanni, Ann Marie; Doulaveris, Georgios; Moo, Tracy-Ann; LaPolla, Dayle; Bakoyiannis, Chris N.; Theodoropoulos, Georgios E.; Zografos, Georgios C.; Andreopoulou, Eleni; Witkin, Steven S.
errShare
errSave
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
err2021-08-23
err47
errOAAI
errLiu, Ying L.; Bager, Cecilie Liv; Willumsen, Nicholas; Ramchandani, Divya; Kornhauser, Naomi; Ling, Lu; Cobham, Marta; Andreopoulou, Eleni; Cigler, Tessa; Moore, Anne; LaPolla, Dayle; Fitzpatrick, Veronica; Ward, Maureen; Warren, J. David; Fischbach, Claudia; Mittal, Vivek; Vahdat, Linda T.
errShare
errSave
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
err2021-06-24
err17
errOAAI
errKearney, Matthew; Franks, Lauren; Lee, Shing; Tiersten, Amy; Makower, Della F.; Cigler, Tessa; Mundi, Prabhjot; Chi, Dow-Chung; Goel, Anupama; Klein, Pam; Andreopoulou, Eleni; Sparano, Joseph; Trivedi, Meghna; Accordino, Melissa; Califano, Andrea; Hershman, Dawn L.; Silva, Jose; Kalinsky, Kevin
errShare
errSave
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
err2021-03-16
err80
errOAAI
errTolaney, Sara M.; Kalinsky, Kevin; Kaklamani, Virginia G.; D'Adamo, David R.; Aktan, Gursel; Tsai, Michaela L.; O'Regan, Ruth M.; Kaufman, Peter A.; Wilks, Sharon T.; Andreopoulou, Eleni; Patt, Debra A.; Yuan, Yuan; Wang, Grace; Savulsky, Claudio; Xing, Dongyuan; Kleynerman, Ella; Karantza, Vassiliki; Diab, Sami
errShare
errSave
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531
err2020-07-15
err8
errOAAI
errAu, CheukMan C.; Furness, John B.; Britt, Kara; Oshchepkova, Sofya; Ladumor, Heta; Soo, Kai Ying; Callaghan, Brid; Gerard, Celine; Inghirami, Giorgio; Mittal, Vivek; Wang, Yufeng; Huang, Xin Yun; Spector, Jason A.; Andreopoulou, Eleni; Zumbo, Paul; Betel, Doron; Dow, Lukas; Brown, Kristy A.
errShare
errSave
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
err2020-06-16
err19
errOAAI
errMarks, Douglas K.; Gartrell, Robyn D.; El Asmar, Margueritta; Boboila, Shuobo; Hart, Thomas; Lu, Yan; Pan, Qingfei; Yu, Jiyang; Hibshoosh, Hanina; Guo, Hua; Andreopoulou, Eleni; Wiechmann, Lisa; Crew, Katherine; Sparano, Joseph; Hershman, Dawn; Connolly, Eileen; Saenger, Yvonne; Kalinsky, Kevin
errShare
errSave
Phase I/II trial of ruxolitinib in combination with trastuzumab in HER2+metastatic breast cancer (MBC)
err2020-02-15
err0
PREAI
errKalinsky, Kevin; Lee, Shing; Tiersten, Amy; Makower, Della F.; Cigler, Tessa; Franks, Lauren; Mundi, Prabhjot; Chi, Dow-Chung; Blumberg, Lauren; Sender, Naomi; Galazyn, Magdalena; Hosi, Kristina; Goel, Anupama; Klein, Paula; Andreopoulou, Eleni; Sparano, Joseph; Crew, Katherine D.; Califano, Andrea; Silva, Jose; Hershman, Dawn L.
errShare
errSave
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
err2020-01-01
err75
errOAAI
errYomtoubian, Shira; Lee, Sharrell B.; Verma, Akanksha; Izzo, Franco; Markowitz, Geoffrey; Choi, Hyejin; Cerchietti, Leandro; Vahdat, Linda; Brown, Kristy A.; Andreopoulou, Eleni; Elemento, Olivier; Chang, Jenny; Inghirami, Giorgio; Gao, Dingcheng; Ryu, Seongho; Mittal, Vivek
errShare
errSave
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
err2019-05-30
err51
errOAAI
errSinn, Bruno, V; Fu, Chunxiao; Lau, Rosanna; Litton, Jennifer; Tsai, Tsung-Heng; Murthy, Rashmi; Tam, Alda; Andreopoulou, Eleni; Gong, Yun; Murthy, Ravi; Gould, Rebekah; Zhang, Ya; King, Tani A.; Viale, Agnes; Andrade, Victor; Giri, Dilip; Salgado, Roberto; Laios, Ioanna; Sotiriou, Christos; Marginean, Esmeralda C.; Kwiatkowski, Danielle N.; Layman, Rachel M.; Booser, Daniel; Hatzis, Christos; Valero, V. Vicente; Symmans, W. Fraser
errShare
errSave
A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
err2019-02-15
err0
PREAI
errLiu, Y. L.; Bager, C. L.; Willumsen, N.; Kornhauser, N.; Cobham, M.; Andreopoulou, E.; Cigler, T.; Moore, A.; LaPolla, D.; Fitzpatrick, V.; Ward, M.; Warren, J. D.; Mittal, V.; Vahdat, L. T.
errShare
errSave
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
err2019-02-01
err138
errOAAI
errLuen, S. J.; Salgado, R.; Dieci, M. V.; Vingiani, A.; Curigliano, G.; Gould, R. E.; Castaneda, C.; D'Alfonso, T.; Sanchez, J.; Cheng, E.; Andreopoulou, E.; Castillo, M.; Adams, S.; Demaria, S.; Symmans, W. F.; Michiels, S.; Loi, S.
errShare
errSave
A randomized phase II trial of fulvestrant with or without ribociclib after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with unresectable or metastatic hormone receptor positive, HER2 negative breast cancer
err2017-02-15
err0
PREAI
errMundi, P. S.; Codruta, C.; Accordino, M. K.; Sparano, J.; Andreopoulou, E.; Vadhat, L. T.; Tiersten, A.; Esteva, F.; O'Regan, R.; Jain, S.; Mayer, I.; Forero, A.; Crew, K. D.; Hershman, D. L.; Kalinsky, K. M.
errShare
errSave